Abstract
We review some principles and implementations of Bayesian model-based adaptive enrichment and population finding designs that exploit biomarker information to propose adaptive treatment allocation and recommend patient subpopulations that might most benefit from the treatments under consideration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barker, A., Sigman, C., Kelloff, G., Hylton, N., Berry, D., and Esserman, L. (2009). I-spy 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clinical Pharmacology & Therapeutics, 86(1), 97–100.
Berry, S. M., Carlin, B. P., Lee, J. J., and Müller, P. (2011). Bayesian Adaptive Methods for Clinical Trials. CRC Press.
Berry, S. M., Broglio, K. R., Groshen, S., and Berry, D. A. (2013). Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials. Clin Trials, 10(5), 720–734.
Chipman, H. A., George, E. I., and McCulloch, R. E. (1998). Bayesian CART model search. Journal of the American Statistical Association, 93(443), pp. 935–948.
Chipman, H. A., George, E. I., and McCulloch, R. E. (2010). BART: Bayesian additive regression trees. Annals of Applied Statistics, 4, 266–298.
Dahl, D. (2006). Model-based clustering for expression data via a Dirichlet process mixture model. In K. Do, P. Müller, and M. Vannucci, editors, Bayesian inference for Gene Expression and Proteomics, pages 201–218. Cambridge: Cambridge University Press.
Denison, D. G. T., Mallick, B. K., and Smith, A. F. M. (1998). A Bayesian CART algorithm. Biometrika, 85(2), pp. 363–377.
Dixon, D. O. and Simon, R. (1991). Bayesian subset analysis. Biometrics, 47, 871–881.
Foster, J. C., Taylor, J. M., and Ruberg, S. J. (2011). Subgroup identification from randomized clinical trial data. Statistics in medicine, 30(24), 2867–2880.
Freidlin, B., McShane, L. M., and Korn, E. L. (2010). Randomized clinical trials with biomarkers: design issues. Journal of the National Cancer Institute, 102(3), 152–60.
Kim, E. S., Herbst, R. S., Wistuba, I. I., Lee, J. J., Blumenschein, G. R., Tsao, A., Stewart, D. J., Hicks, M. E., Erasmus, J., Gupta, S., et al. (2011). The BATTLE trial: personalizing therapy for lung cancer. Cancer Discovery, 1(1), 44–53.
Medvedovic, M., Yeung, K. Y., and Bumgarner, R. E. (2004). Bayesian mixture model based clustering of replicated microarray data. Bioinformatics, 20(8), 1222–1232.
Ruberg, S. J., Chen, L., and Wang, Y. (2010). The mean does not mean as much anymore: finding sub-groups for tailored therapeutics. Clinical Trials, 7(5), 574–583.
Sargent, D. J., Conley, B. A., Allegra, C., and Collette, L. (2005). Clinical trial designs for predictive marker validation in cancer treatment trials. Journal of Clinical Oncology, 23(9), 2020–2027.
Simon, R. (2002). Bayesian subset analysis: application to studying treatment-by-gender interactions. Statistics in Medicine, 21(19), 2909–2916.
Simon, R. (2012). Clinical trials for predictive medicine. Stat Med, 31(25), 3031–3040.
Simon, R. and Maitournam, A. (2004). Evaluating the efficiency of targeted designs for randomized clinical trials. Clinical Cancer Research, 10(20), 6759–6763.
Sivaganesan, S., Laud, P. W., and Müller, P. (2011). A Bayesian subgroup analysis with a zero-enriched polya urn scheme. Statistics in medicine, 30(4), 312–323.
Sivaganesan, S., Laud, P. W., and Müller, P. (2013). Subgroup analysis. In P. Damien, P. Dellaportas, N. Polson, and D. Stephens, editors, Bayesian Theory and Applications, pages 576–592. Oxford University Press.
Xu, Y., Trippa, L., Müller, P., and Ji, Y. (2014). Subgroup-Based Adaptive (SUBA) Designs for Multi-arm Biomarker Trials. Statistics in Biosciences, pages 1–22.
Yin, G. (2012). Clinical Trial Design: Bayesian and Frequentist Adaptive Methods. Wiley.
Zhou, X., Liu, S., Kim, E. S., Herbst, R. S., and Lee, J. J. (2008). Bayesian adaptive design for targeted therapy development in lung cancer–a step toward personalized medicine. Clin Trials, 5(3), 181–193.
Acknowledgements
Yuan Ji and Peter Müller’s research is partially supported by NIH R01 CA132897.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Xu, Y., Ji, Y., Müller, P. (2015). Biomarker-Driven Adaptive Design. In: Mitra, R., Müller, P. (eds) Nonparametric Bayesian Inference in Biostatistics. Frontiers in Probability and the Statistical Sciences. Springer, Cham. https://doi.org/10.1007/978-3-319-19518-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-19518-6_15
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19517-9
Online ISBN: 978-3-319-19518-6
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)